|
Patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) can benefit from Glofitamab Injection in India, a targeted therapy that helps activate the immune system to fight cancer cells. Impomed Healthcare facilitates access to this advanced treatment, ensuring reliable oncology solutions for those in need of effective care.
|